Preclinical services for biopharmaceutical product development
Award Notice Posted
- Solicitation number
- 75N93022R00004
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Allucent Government Services (Us) LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93023D00011 Federal IDV award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Houston, Texas 77060, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a contract to PHARM-OLAM, LLC for preclinical services for biopharmaceutical product development. The indefinite-delivery/indefinite-quantity contract has a minimum value of $2,000 and maximum value of $30,000,000 across two task areas: product development planning and evaluation; and regulatory activities and documentation. The contract awarded to PHARM-OLAM, LLC is valued at $30,000,000.
Notice text
IDIQ Contract Award
Minimum $2,000
Maximum $30,000,000
Task Areas Awarded
Task Area A - Product Development Planning and Evaluation
Task Area E - Regulatory Activities and Documentation
Awarded contract 75N93023D00011 to PHARM-OLAM, LLC for 30000000.00 on 2023-09-08.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Preclinical services for biopharmaceutical product development | Award Notice | |
| Preclinical services for biopharmaceutical product development | Award Notice | |
| Preclinical services for biopharmaceutical product development | Award Notice | |
| This notice | Award Notice | |
| Preclinical services for biopharmaceutical product development | Solicitation | |
| Preclinical services for biopharmaceutical product development | Pre-Solicitation | |
| Preclinical services for biopharmaceutical product development | Pre-Solicitation |
7 of 10 notices listed here. See the rest on GovTribe.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside | |
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity